Abbott Laboratories (ABT) Dividends Paid - Common Growth (3y) (2012 - 2026)
Abbott Laboratories (ABT) Dividends Paid - Common Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 7.38% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 5.75% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 0.11% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -16.01% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -599.76% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 9.77% |
| 10 | Zimmer Biomet Holdings | 19.26 Bn | 18.85 Bn | 1.54 Bn | -2.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.38% |
| Mar 31, 2026 | 7.25% |
| Dec 31, 2025 | 7.77% |
| Sep 30, 2025 | 7.67% |
| Jun 30, 2025 | 7.51% |
| Mar 31, 2025 | 7.24% |
| Dec 31, 2024 | 6.28% |
| Sep 30, 2024 | 6.22% |
| Jun 30, 2024 | 6.17% |
| Mar 31, 2024 | 6.16% |
| Dec 31, 2023 | 11.48% |
| Sep 30, 2023 | 11.59% |
| Jun 30, 2023 | 11.50% |
| Mar 31, 2023 | 11.74% |
| Dec 31, 2022 | 13.16% |
| Sep 30, 2022 | 13.23% |
| Jun 30, 2022 | 13.39% |
| Mar 31, 2022 | 13.77% |
| Dec 31, 2021 | 17.26% |
| Sep 30, 2021 | 17.48% |